Balyasny Asset Management’s NovoCure NVCR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$40.4M Buy
2,270,076
+634,925
+39% +$11.3M 0.06% 312
2025
Q1
$29.1M Buy
1,635,151
+566,288
+53% +$10.1M 0.05% 350
2024
Q4
$31.9M Buy
1,068,863
+229,689
+27% +$6.84M 0.05% 359
2024
Q3
$13.1M Buy
839,174
+244,176
+41% +$3.82M 0.02% 587
2024
Q2
$10.2M Buy
594,998
+167,719
+39% +$2.87M 0.02% 633
2024
Q1
$6.68M Buy
427,279
+110,476
+35% +$1.73M 0.01% 794
2023
Q4
$4.73M Sell
316,803
-792,812
-71% -$11.8M 0.01% 797
2023
Q3
$17.9M Buy
1,109,615
+250,509
+29% +$4.05M 0.04% 461
2023
Q2
$35.7M Buy
859,106
+501,077
+140% +$20.8M 0.08% 293
2023
Q1
$21.5M Buy
+358,029
New +$21.5M 0.05% 391
2022
Q3
Hold
0
2635
2022
Q2
Sell
-37,593
Closed -$3.12M 2574
2022
Q1
$3.12M Sell
37,593
-38,373
-51% -$3.18M 0.01% 901
2021
Q4
$5.7M Buy
75,966
+66,614
+712% +$5M 0.02% 682
2021
Q3
$1.09M Buy
+9,352
New +$1.09M ﹤0.01% 1091
2020
Q4
Sell
-80,588
Closed -$8.97M 1381
2020
Q3
$8.97M Sell
80,588
-280,467
-78% -$31.2M 0.07% 356
2020
Q2
$21.4M Buy
+361,055
New +$21.4M 0.19% 136
2019
Q3
Sell
-20,236
Closed -$1.28M 1299
2019
Q2
$1.28M Buy
20,236
+9,189
+83% +$581K 0.01% 877
2019
Q1
$532K Buy
+11,047
New +$532K ﹤0.01% 1087
2018
Q4
Sell
-9,165
Closed -$480K 1481
2018
Q3
$480K Buy
+9,165
New +$480K ﹤0.01% 1174
2018
Q2
Sell
-29,036
Closed -$633K 1819
2018
Q1
$633K Buy
+29,036
New +$633K ﹤0.01% 1189